Relations of GlycA and Lipoprotein Particle Subspecies with Cardiovascular Events and Mortality: A Post Hoc Analysis of the AIM-HIGH Trial

BACKGROUND: The AIM-HIGH Trial showed no incremental benefit of extended-release niacin (ERN) therapy added to simvastatin in subjects with cardiovascular disease (CVD). OBJECTIVES: To examine the effects of ERN treatment on lipoprotein particles and GlycA, a new marker of systemic inflammation, and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Lipidol
Main Authors: Otvos, James D., Guyton, John R., Connelly, Margery A., Akapame, Sydney, Bittner, Vera, Kopecky, Steven, Lacy, Megan, Marcovina, Santica M., Muhlestein, Joseph B., Boden, William E.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5931743/
https://ncbi.nlm.nih.gov/pubmed/29409728
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacl.2018.01.002
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados